Pathology, histology: Page 3

Raziel Health, Baptist Health partner on telehealth in Florida

By LabPulse.com staff writers

Raziel's platform enables physicians and care teams to extend continuous medical services into the homes of chronically ill patients, inpatients with complex disease conditions, and those transitioning from a hospital to their homes.

September 21, 2022

Paige, OptraScan partner to push digital pathology adoption

By LabPulse.com staff writers

The companies aim to reduce barriers to the adoption of digitizing glass pathology slides, which will in turn enhance workflows in pathology and oncology, Paige said.

September 21, 2022

Innovative Health launches B2B platform for at-home testing

By LabPulse.com staff writers

Digital health organizations can utilize Innovative Health's partner platform to offer consumers more than 70 different at-home tests that detect conditions, including infectious diseases and women's and men's health concerns, the firm said.

September 20, 2022

BrightInsight, BioMérieux partner on digital health

By LabPulse.com staff writers

The aim is to improve clinical workflows and deliver actionable data to cross-functional care teams, the companies said.

September 20, 2022

Vizgen kit enables subcellular, spatial multiomics measurement

By LabPulse.com staff writers

While RNA imaging can resolve the gene expression at a single-cell level and help annotate the cell state in complex tissue, information such as cell morphology and pathological features can only be imaged by proteins.

September 19, 2022

VIC Foundry receives $259K NIH grant

By LabPulse.com staff writers

VIC Foundry will use the funds to develop a microwave microreactor for in-situ capture and digestion of target proteins, leveraging an acceleration effect of a unique microwave resonator on the binding and pyrolytic reaction rates, the company said.

September 19, 2022

Neogen launches immunoassay to detect cashew allergens

By LabPulse.com staff writers

The Veratox VIP for Cashew allergen test is the second in Neogen's Veratox VIP series of enhanced quantitative enzyme-linked immunoassay (ELISA) products. According to the company, it demonstrates a high level of specificity to very low levels of cashew protein, down to 0.2 ppm.

September 18, 2022

Wearable device measures tumor size changes under the skin

By Jared Berberabe

The device may provide an inexpensive and hands-free way to evaluate the efficacy of cancer drugs and could lead to promising new directions in cancer treatment, its developers said.

September 15, 2022

Aignostics nabs 14M euros in Series A financing

By LabPulse.com staff writers

The company, a 2018 spinoff from the Digital Health Accelerator program at the Berlin Institute of Health, said that it is developing novel digital pathology solutions with its Explainable AI technology for pharmaceutical research and diagnostics.

September 15, 2022

Deciphex: Pathology platform validated in digital GLP study

By LabPulse.com staff writers

Patholytix, a research pathology and workflow platform, has been validated in a fully digital Good Laboratory Practice (GLP) study, the firm said.

September 15, 2022

Prometheus, Takeda launch prognostic tool for Crohn’s

By LabPulse.com staff writers

According to Prometheus, CDPath is a personalized risk assessment tool that can be used in combination with a physician's clinical assessment to evaluate an adult patient's risk for developing serious complications of CD such as bowel strictures, internal penetrating disease, or non-perianal surgery within three years.

September 14, 2022

Nordic touts PRO-C6 biomarker for heart failure clinical trials

By LabPulse.com staff writers

In collaboration with Bristol Myers Squibb and the University of Pennsylvania, researchers combined analyses of six independent cohorts of HFpEF patients from around the globe, which are being evaluated with the PRO-C6 biomarker.

September 13, 2022

Previous Page

Page 3 of 164

Next Page